Chronic dosing amplifies rare signals
Prigeon RL, Quddusi S, Paty B, D'Alessio DA (2003) Suppression of glucose production by GLP-1 independent of islet hormones: A novel extrapancreatic effect
One systematic review and meta-analysis found that, when used alongside standard treatments, these medications can significantly reduce body weight, BMI, and waist circumference
Conclusion Adjusting your weight loss goals while using GLP-1 medications isnt something you do just once its a continuous process
GLP-3, a novel triple agonist of the GIP, GLP-1, and GCG receptors, has demonstrated significant hepatoprotective effects in research involving individuals with MASLD
However, research indicates that active GLP-1 (7-36) amide is the most predominant form in circulation and can provide an accurate representation of active GLP-1 levels 11, 12